In this compelling conversation with Charles Spence on the “A Dose of Reality” podcast, our President of R&D, Peter Tummino, dives into the importance of company culture in driving scientific innovation. At the heart of Nimbus’s success, Peter reveals, is our unwavering belief that scientists should lead the way in drug discovery. He also shared thoughtful perspectives on industry trends, including realistic expectations around AI in drug discovery and the continued importance of focusing on fundamental scientific challenges.

The podcast offers an authentic glimpse into Peter’s leadership philosophy and our company’s dedication to developing breakthrough medicines through rigorous science and outstanding execution.

Listen to the full episode: Peter Tummino, President of R&D at Nimbus Therapeutics – Drugging the Undruggable, The TYK2 Success Story, and Overhyping AI in Drug Discovery